Статья
СОВРЕМЕННЫЕ ПОДХОДЫ К ДИАГНОСТИКЕ И ЛЕЧЕНИЮ БЕЗБОЛЕВОЙ ИШЕМИИ МИОКАРДА
Современные подходы к диагностике и лечению безболевой ишемиимиокарда.
1. Безболевая ишемия миокарда, М.- 1995. Вёрткин А.Л., Мартынов И.В., Гасилин В.С., Мартынов А.И., Тополянский А.В., Круглов В.А.
2. Боев С.С. Безболевая ишемия миокарда у больных со стабильной стенокардией напряжения и постинфарктным кардиосклерозом. 1998.
3. Бочкарева Е.В., Кондратьев В.В., Кокурина Е.В., Кучерявая Н.Г и др. Прогнозирование бессимптомной ишемии миокарда у больных со стабильной стенокардией по результатам теста с физической нагрузкой. Кардиология, 1997; 7, 24- 28.
4. Бочкарева Е.В., Кондратьев В.В., Кокурина Е.В. и др. Тактильная и болевая чувствительность кожи у больных со стенокардией с различной выраженностью проявлений безболе- вой ишемии миокарда. Кардиология 1997; 3: 12-6.
5. Бочкарева Е.В., Кокурина Е.В., Метелица В.И, Кондратьев В.В и др. Влияние препаратов, применяемых в кардиологии, на болевую чувствительность у больных со стенокардией. Кардиология 2000; 7, том 40: 16-22.
6. Водопьянова Р.С. Метод суточного мониторирования ЭКГ в оценке эффективности длительного применения антиангинальных препаратов у больных со стабильной стенокардией. Автореф. дисс. …канд. мед. наук, М.,1992; 22.
7. Дубов П.Б., Коняева Е.Б., Остроумов Е.Н., Сергиенко В.Б. и др. Гипертоническая болезнь и «немая» ишемия миокарда. Сообщение. I. Результаты нагрузочной сцинтиграфии миокарда у больных гипертонической болезнью. Тер. архив, 1992; 9-12.
8. Зайцев А.А. Адренергические механизмы регуляции боле- вой чувствительности и болеутоляющего действия наркотических анальгетиков. Фармакодинамика болеутоляющих средств в эксперименте и клинике. Сборник научных трудов. Л.- 1991; 69-95.
9. Кондратьев В.В. Состояние тактильной и болевой чувствительности кожи у больных со стабильной стенокардией напряжения и эпизодами безболевой ишемии миокарда: Автореф. дисс… канд.мед. наук. М.- 1996; 28.
10. Кондратьев В.В., Бочкарева Е.В., Кокурина Е.В. Безболевая ишемия миокарда. Современное состояние проблемы и клинически значимые аспекты ее развития. II. Механизмы формирования безболевой ишемии миокарда. Кардиология 1997; 2:90-97.
11. Коняева Е.Б., Косенко А.И., Дубов П.Б., Юренев А.П. Безболевое снижение сегмента ST при суточном мониторировании ЭКГ у больных гипертонической болезнью. Тер. архив, 1991; 4: 40-4.
12. Кукушкин М.Л., Смирнова В.С., Горизонтова М.П. Влияние клофелина и пропранолола на развитие нейрогенного болевого синдрома у крыс. Пат. физиол. 1993; 4: 16-19.
13. Кукушкин С.К., Голожилов В.А., Маношкина С.М., Шашарин В.М. Сопоставление бессимптомных и зменений ЭКГ срезультатами ЭхоКг при массовых обследованиях населения в условиях скрининг-диагностического комплекса.
14. Лихачева С.Б., Арасланова М.С., Загидуллин Ш.З. Секция 3. Холтеровское мониторирование ЭКГ. Взаимосвязь ишемии миокарда и вегетативного статуса больных ИБС по данным холтеровского мониторирования ЭКГ.
15. Лякшиев АА. Метод ХМЭКГ по оценке безболевой ишемии миокарда у больных с ишемической болезнью сердца.
16. Маликов В.Е. и др. Руководство по реабилитации больных ишемической болезнью сердца после операции аортокоронарного шунтирования.-М.: изд-во НЦССХ им. А.Н. Бакулева РАМН, 1999.- 106 с.
17. Мартынов И.В., Верткин А.Л., Жаров Е.И., Мартынов А.И. Безболевая ишемиямиокарда глазамиклинициста. Клин. медицина, 1991; 8: 22-6.
18. Пшеницин А.И., Глотов М.Н., Мазур Н.А. «Немая» ишемия миокарда у больных артериальной гипертензией и влияние на нее антигипертензивных препаратов. Русский медицинский журнал, 1997, май; том 5, номер 9.
19. Пшеничников И., Шипилова Т., Лаане П. Значение безболевой ишемиимиокарда в определении ближайшего прогноза у больных ишемической болезнью сердца со стабильной стенокардией. Кардиология, 1996; 7: 11-15.
20. Сыркин А.Л., Дроздов Д.В. Бессимптомная ишемиямиокарда. Кардиология, 1992; 32, том 7-8, стр 106-12
21. Ardissino D., Merlini P.A., Gamba G. et al. Trombin activity and early outcome in unstable angina pectoris. Circulation, 1996; 93: 1634-39.
22. Arnim T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis. Results of TIBBS follow-up. J. Am. Coll. Cardiol. 1996; 28 (20-4).
23. Arnim T., Maseri A. Silent ischemia: current concepts and management. Darmstadt: Steinkopff Verlag, 1987: 140-146.
24. Asmar R., Benetos A., Pannier B. et al. Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemis hypertension. Am. J. Cardiol. 1996; 77 (5): 384-90.
25. Atar S., Cercek B., Nagai T., Luo H. et al. Transthoraciс stress echocardiography with transesophageal atrial pacing for bedside evaluation of inducible myocardial ischemia in patients with new�onset chest-pain. Am. J. Cardiol. 2000; 86: 12-16.
26. Bairey C.N., Krantz D.S., Dequattro V. et al. Effects of beta-blocade on low heart rate-related ischemia during mental stress. J Am. Coll. Cardiol. 1991; 17 (6): 1388-95.
27. Bech J., Madsen J.K., Kelbaek H. Amlodipine reduces myocardial ischaemia during exercise without compromising left ventricular function in patients with silent ischaemia: a randomised, double-blind, placebo-controlled study. Eur.J.Heart Fail. 1999 Dec; 1 (4): 395-400.
28. Ben-Streti M., Gonzales J., Sewell R. Effects of elevated calcium and calcium antagonists in 6,7-benzomorthan induced analgesia. Eur. J. Pharmacol. 1983; 90: 385.
29. Blumenthal J.A., Jiang W., Babyak M.A. Stress management and exercise treatment in cardiac patients with myocardial ischemia: effects on prognosis and evaluation of mechanisms. Arch. Intern. Med. 1997; 157 (19): 2213-2223.
30. Bourassa M.G., Pepine C.J., Forman S.A., Rogers W.J. et al. Asymptomatic Cardiac Ischemia Pilot (ASIP) Study: effects of coronary angioplasty and coronary artery bypass graft surgery on reccurent angina and ischemia. J. Am. Coll. Cardiol. 1995, 26 (3): 606-14.
31. Brue R.A., DeRouen T.A., Waters D.D. et al. Circulation 1987; 75: 988-1006.
32. Bugiardini R., Conti R. Unstable angina: prognosis of the individual patient. Clin. Cardiol. 1998; 21: 706-710.
33. Candell-Riera J., Santana-Boado C., Bermejo B., Castell-Conesa J et al. Prognosis of “clandestine” myocardial ischemia, silent myocardial ischemia, and angina pectoris in medically treated patients. Am. J. Cardiol. 1998; 82: 1333-1338.
34. Caracciolo E.A., Chaitman B.R., Forman S.A., Stone P.H. et al. Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. Circulation 1996; 93: 2097-2105.
35. Casella G., Pavesi P., Medda M., diNiro M. et al. Long-term prognosis of painless exercise-induced ischemia in stable patients with previous myocardial infarction. Am. Heart J. 1998; 136: 894-904.
36. Cesar L.A.M., Ferreira J. F.M., Grupi C.J., Pamplona D. et al. Does a circadian variation occur in myocardial ischemia over 48 hours in patients with unstable angina? Arq. Bras. Cardiol. July 2000; Vol 75, Number 1.
37. Chaitman B.R., Stone P.H., Knatterud G.L., Forman S.A. et al. Asymptomatic Cardiac Ischemia Pilot (ASIP) Study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. J. Am. Coll. Cardiol. 1995; 26: 585-93.
38. Cohen J.D. Abnormal electrocardiograms and cardiovascular risk: role of silent myocardial ischemia. Am.J.Cadiol.1992; 70: 14F-18F.
39. Cohn P.F. Silent myocardial ischemia and infarction; Third Edition, New-York; Markel Decker Inc, 1993.
40. Crea F., Pupita G., Gallasi A. et al. Role of adenosine in pathogenesis of anginal pain. Circulation 1990; 81: 164-172.
41. Davies E., Bencivelli W., Frasso G. et al. Sequence and magnitude of ventricular volume changes in painful and painless myocardial ischemia. Circulation 1988; 78: 310-319.
42. Deanfield J.E., Ribeiro P., Oakley K., Krikler S. et al. Analysis of ST-segment changes in normal subjects: implications for ambulatory monitoring in angina pectoris. Am J Cardiol 1984; 54:1321-1325.
43. Deedwania P.C., Carbajal E.V. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990; 81: 748-756.
44. Dellborg M., Malmberg K., Ryden L., Sveensson A. et al. Dynamic on-line vectorcardiography improves and simplifies in hospital ischemia monitoring of patients with unstable angina. J. Am. Coll. Cardiol. 1995; 26: 1501-1507.
45. Duarte I., dos Santos I., Lorenzetti B. Analgesia by direct antagonism of nociceptor sensitisation involves the arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 1992; 217: 225-227.
46. Egstrup K., Andersen P. Transient myocardial ischemia taking nifedipine therapy in stable angina pectoris and its relations to coronary collateral flow and comparison with metoprolol. Am. J. Cardiol. 1993; 71: 177-183.
47. Falcone C., Sconocchia R., Guasti L., Codega S. et al. Dental pain threshold and angina pectoris in patients with coronary artery disease. J. Am. Coll. Cardiol. 1998; 12: 348-52.
48. Falcone C., Specchi G., Rondanelli R. et al. Correlation between beta-endorphin plasma levels and anginal symptoms in patients coronary artery disease. J. Am. Coll. Cardiol. 1998; 11: 719-23.
49. Fearon W.F., Lakshmi J., Atwood E., Froelicher V. Should only the squeaky wheel get the grease? The prognostic significance of silent ischemia detected by exercise treadmill testing. Am. Heart J. Nov. 1998; Vol 136, Number 5: 759-61.
50. Fleg J.L., Gersterblith C., Zonnerman A.B. et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and ECG in asymptomatic volunteers. Circulation 1990; 81: 428-36.
51. Gabbay F.H., Krantz D.S., Kop W.J. et al. Triggers of myocardial ischemia during daily life in patients with coronary artery disease: physical and mental activities, anger and smoking. J. Am. Coll. Cardiol. 1996; 27 (3): 585-592.
52. Gettes L. Painless myocardial ischemia. Chest 1974; 66: 612-13.
53. Gill J.B., Cairns J.A., Roberts R. et al. Prognostic importance of MI detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996; 334: 65-70.
54. Gottlieb S.O., Weisfeldt M.L., Quyang P., Mellits E.D. et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N. Engl. J. Med. 1986; 314: 1214-1219.
55. Gullette E., Blumenthal J.A., Babyak M. Effects of stress on myocardial ischemia during daily life. JAMA 1997, 277 (20): 1521-26.
56. He et al. Severity of coronary artery calcification by electron beam tomography predicts silent myocardial ischemia. Circulation 2000 Jan 25; 101: 244-251.
57. Hering D., Schulteiss H-P., Horstkotte D. Significance of silent myocardial ischemia for the identification and optimal therapy of patients with latent coronary artery disease. Does percutaneous transluminal coronary angioplasty improve prognosis? Herz 1999;1: 72-84.
58. Heusch G., Schulz R. The relation of contractile function to myocardial perfusion. Perfusion-contraction match and mismatch. Herz, 1999; 24: 509-514.
59. Hikita H., Etsuda H., Takase B., Satomura K. et al. Extent of ischemic stimulus and plasma β-endorphin levels in silent myocardial ischemia. Am. Heart J. 1998; 135: 813-8.
60. Homvang L., Andersen K., Dellborg M., Clemmensen P. et al. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuos electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am. J. Cardiol. 1999; 83: 667-674.
61. Kang X., Berman D.S., Lewin H., Miranda R. et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am. Heart J. 1999; 137: 949-57.
62. Kathirezan S., Jordan M.J., Gimelli G., Lopez-Cuellan J. et al. Frequency of silent myocadial ischemia following coronary stenting. Am. J. Cardiol. Vol 84, Oct 15, 1999; 930-932.
63. Katzel L.I., Sorkin J.D., Colman E., Goldberg A.P. et al. Risk factors for exercise-induced silent myocardial ischemia in healthy volunteers. Am. J. Cardiol. 1994; 74: 869-874.
64. Klein J., Chao S.Y., Berman D.S., Rozanski A. Is “silent” myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation 1994; 89: 1958-1966.
65. Kloner R.A., Yellon D. Does ischemic preconditionning occurs in patients? J. Am. Coll. Cardiol. 1994; 24, 1133 – 42.
66. Klooteijk P., Meij S., Melkert R., Lenderink T. et al. Reduction of reccurent ischemia with abciximab during continious ECG-ischemia monitoring in patients with unstable angina refractory to standart treatment (CAPTURE). Circulation 1998; 98: 1358-64.
67. Kohya T., Tomita F., Iton K et al. Silent myocardial ischemia during Holter monitoring in ischemic heart disease. Jpn. Circul. J. 1989; 53: 1399-1406.
68. Langer A., Freeman M.R., Josse R.G., Steiner G. et al. Detection of silent myocardial ischemia in diabetes mellitus. Am. J. Cardiol. 1991; 67: 1073-1078.
69. Langer A., Minkowitz A., Dorian P. et al. Pathophysiology and prognostic significance of Holter-detected ST-segment depression after myocardial infarction. J. Am. Coll. Cardiol. 1992; 20: 1313-1317.
70. Lanza G.A. Silent ischemia detection by long-term ECG recording. J. Intern. Soc. Bioelectromagn. 2000, vol 2, N1
71. Lee D., Kimura S., DeQuattro V. Lancet 1989; 1: 403-406.
72. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 1986; 111 (2): 383-390.
73. Levenson J., Mishra A., Hamer R., Hastillo A. Denial and medical outcome in unstable angina. Psychosom. Med. 1989; 51: 27-35.
74. Ma S., Long J. Central noradrenergic activity is responsible for nitroglycerin-induced cardiovascular effects in the nucleus tracus solitarii. Brain Res. 1991; 559: 297-303.
75. Maciewicz R., Martin J. Pain: pathophysiology and managemen. Harrison“s principles of internal medicine. 12th ed. New-York: McGraw Hill 1991; 93-98.
76. Maseri A., Crea F., Kaski J., Davies G. Mechanisms and significance of cardial ischemic pain. Progr. Cardiovasc. Dis. 1992; 35: 1-18.
77. May O., Arildsen H., Damsgaard E.M., Mickley H. Prevalence and prediction of silent ishemia in diabetes mellitus: a population�based study. Cardiovasc. Res. 1997; 34: 241-247.
78. Mazzone A., Mazzucchelli I., Vezzoli M., Ottini E. et al. Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia. J. Am. Coll. Cardiol. 2000 Sep; 36 (3): 746-50.
79. Murray G.J.L., Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
80. Myrtek M., Fichtler A., Konig K et al. Differences between patients with symptomatic and asymptomatic myocardial infarction the relevance of psychological factors. Eur. Heart J. 1994; 15: 311-317.
81. Naka M., Hiramutsu K., Aizawa T., Momose A. et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am. Heart J. 1992; 123: 46-53.
82. Narula A.S., Jha V., Bali H.K., Sakhuja V. et al. Cardiac arrhythmias and silent myocardial ischemia during hemodialysis. Ren. Fail 2000 May; 22 (3): 355-68.
83. Ness T., Gebhart G. Visceral pain: a review of experimental studies. Pain 1990; 41: 167-234.
84. Nesto R., Phillips R., Kett K. et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by thallium scintigraphy. Ann. Intern. Med. 1988; 108: 170-175.
85. Parmley W.W. Prevalence and clinical significance of silent myocardial ischaemia. Circulation 1989; 80:68-73.
86. Patel D.J., Knight C.J., Holdright D.R., Mulcahy D. et al. Long-term prognosis in unstable angina: the importance of early risk stratification using continuos ST segment monitoring. Eur. Heart J. 1998; 19: 240-249.
87. Patel D.J., Knight C.J., Holdright D.R., Mulcahy D. et al. Pathophysiology of transient myocardial ischemia in acute coronary syndromes. Circulation 1997; 95: 1185-92.
88. Pepine C.J., Cohn P.F., Deedwania P.C. et al. for the ASIST study group. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994; 90: 762-8.
89. Picaso E., Lucarini A.R., Lattanri F., Marini C. ST-segment depression elicited by dipyridamole infusion in asymptomatic hypertensive patients. Hypertension 1990; 16: 19-25.
90. Pozzati A., Bugiardini R., Borghi A., Ottani F. et al. Transient ischaemia refractory to conventional medical treatment in unstable angina: angiographic correlates and prognostic implications. Eur. Heart J. 1992; 13:360-365.
91. Rebuzzi A., Quaranta G., Lanza G.A., Liuzzo G. et al. Incremental prognostic value of serum levels of troponin T and C- reactive protein on admission in patients with unstable angina pectoris. Am. J. Cardiol. 1998; 82: 715-719.
92. Rogers W.J., Bourassa M.G., Andrews T.C. et al. Asymptomatic Cardiac Ischemia Pilot (ASIP) Study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomised to medical therapy or revascularisation. J. Am. Coll. Cardiol. 1995; 26: 594-605.
93. Romeo F., Rosano G.M.C., Martuscelli E., Valente A. et al. Unstable angina: role of silent ischemia and total ischemic time (silent plus painful ischemia): a 6-year follow-up. J.Am.Coll.Cardiol. 1992; 19:1173-1179.
94. Rosen S.D., Paulesu E., Nihoyannopoulos P., Tousoulis D. et al. Silent ichemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann. Inter. Med. 1996; 124: 939-49.
95. Rutter M.K., McComb J.M., Brady S., Marshall S.M. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am. J. Cardiol. 1999; 83: 27-31.
96. Salcedo E.E., Marwick T.H., Korzick D.H. et al. Left ventricular hypertrophy sensitizes the myocardium to the development of ischemia. Eur. Heart J. 1990; 11 (Suppl G): 72-8.
97. Sasaki A., Arai T., Shigeta H., Ibukiyama C. Detection of silent myocardial ischemia patients by the spatial velocity electrocardiogram. Am. J. Cardiol. 1999 Nov; Vol 84, Number 1: 1081-1083.
98. Schroeder A.P., Brysting B., Sogaard P., Pedersen O.L. Silent myocardial ischaemia in untreated essential hypertensives. Blood Press 1995; 4(2): 97-104.
99. Sigurdsson E., Thorgeirsson G., Sigvaldason H., Sigfusson N. Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur. Heart J. 1993; 14: 584-91.
100. Sigurdsson E., Thorgeirsson G., Sigvaldason H., Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. Ann. Intern. Med. 15 Jan 1995; 122: 103-106.
101. Silent myocardial ischemia. Edited by Shlomo Stern,1998, 208pp.
102. Singh N., Langer A. Current status of silent myocardial ischemia. Can. J. Cardiol. 1995; 11 (4): 286-289.
103. Subramanian V., Bowles M., Khurmi N. et al. Randomised double�blind comparison of verapamil and nifedipine in chronic stable angina. Am. J.Cardiol. 1982; 50: 696-703.
104. Unzueta-Montoya A., de la Pena E.J., Rubio A.T.G., Unzueta A. et al. Risk factors related to the occurence of silent myocardial ischemia in mexicans. Clin. Cardiol. 2000; 23: 248-252.
105. Wexler L., Brundage B., Crouse J., Detrano R. et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation 1996 Sep; Vol 94, 5:1175-1192.
106. Williams K.A., Taillon L.A., Carter J.E. Asymptomatic and electrically silent myocardial ischemia during upright leg cicle ergometry and treadmill exercise (clandestine myocardial ischemia). Am. J. Cardiol. 1993; 72: 114-1120.
107. Willich S., Pohjola- Sintonen S., Bhatia S. et al. Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease. Circulation 1989; 73: 557-565.
108. Willis W. Nociceptive pathways: anatomy and physiology of nociceptive ascending pathways. Nociception and pain. London: Roy Soc. 1985; 292-298.
109. Yano K., MacLean C.J. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. Arch. Intern. Med. 1989; 149:1528-32.